ESMO BREAST 2021 - Breast Cancer Index and prediction of extended endocrine therapy / late relapse

ESMO BREAST 2021 - HER2-low breast cancer - what is it anyway?

Q&A with Dr. Melanie Spears on the Characterisation of immune “hot” ER+ breast cancer

ESMO 2021 - HER2-low breast cancer: evolution from primary breast cancer to relapse

Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective